P53 Down-regulates SETDB1 gene expression during paclitaxel induced-cell death

Biochemical and Biophysical Research Communications

Volumn 446, Issue 1, 2014, Pages 43-48

  Noh, Hee Jung ^a   Kim, Kyeong Ah ^a   Kim, Keun Cheol ^a  

^a Kangwon National University   (South Korea)

Author keywords

H3K9me3; p53; Paclitaxel; SETDB1; SUV39H1

Indexed keywords

HISTONE H3; HISTONE METHYLTRANSFERASE; PACLITAXEL; PROTEIN P53; SETDB1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL DEATH; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DOWN REGULATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; HETEROCHROMATIN; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG CANCER; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

H3K9ME3; P53; PACLITAXEL; SETDB1; SUV39H1;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BINDING SITES; CELL DEATH; CELL LINE, TUMOR; DOWN-REGULATION; G2 PHASE CELL CYCLE CHECKPOINTS; HISTONES; HUMANS; LUNG NEOPLASMS; PACLITAXEL; PROMOTER REGIONS, GENETIC; PROTEIN METHYLTRANSFERASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84898000414     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.02.053     Document Type: Article

References (30)

1. Y. Wang, Y. Li, X. Liu, and W.C. Cho Genetic and epigenetic studies for determining molecular targets of natural product anticancer agents Curr. Cancer Drug Targets 13 2013 506 518
2. B. Pang, X. Qiao, L. Janssen, A. Velds, T. Groothuis, R. Kerkhoven, M. Nieuwland, H. Ovaa, S. Rottenberg, O. van Tellingen, J. Janssen, P. Huijgens, W. Zwart, and J. Neefjes Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin Nat. Commun. 4 2013 1908
3. G. Bocci, A. Di Paolo, and R. Danesi The pharmacological bases of the antiangiogenic activity of paclitaxel Angiogenesis 16 2013 481 492
4. C. Best, D. Calianese, K. Szulak, G. Cammarata, G. Brum, T. Carbone, E. Still, K. Higgins, F. Ji, W. Di, H. Wanebo, and Y. Wan Paclitaxel disrupts polarized entry of membrane-permeable C6 ceramide into ovarian cancer cells resulting in synchronous induction of cell death Oncol. Lett. 5 2013 1854 1858
5. P.M. Soetekouw, J.N. Timmer-Bonte, M.A. van der Drift, F. van Leeuwen, M. Wagenaar, L. van Die, J. Bussink, and V.C. Tjan-Heijnen Safety and efficacy of sequential chemotherapy with carboplatin plus gemcitabine followed by weekly paclitaxel in advanced non-small cell lung cancer Int. J. Clin. Oncol. 18 2013 988 996
6. S. Singh, and A.K. Dash Paclitaxel in cancer treatment: perspectives and prospects of its delivery challenges Crit. Rev. Ther. Drug Carrier Syst. 26 2009 333 372
7. A. Sunters, P.A. Madureira, K.M. Pomeranz, M. Aubert, J.J. Brosens, S.J. Cook, B.M. Burgering, R.C. Coombes, and E.W. Lam Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-jun NH2-terminal kinase and akt Cancer Res. 66 2006 212 220
8. G. Tudor, A. Aguilera, D.O. Halverson, N.D. Laing, and E.A. Sausville Susceptibility to drug-induced apoptosis correlates with differential modulation of bad, bcl-2 and bcl-xL protein levels Cell Death Differ. 7 2000 574 586
9. Y. Wu, F. Sato, U.K. Bhawal, T. Kawamoto, K. Fujimoto, M. Noshiro, S. Morohashi, Y. Kato, and H. Kijima Basic helix-loop-helix transcription factors DEC1 and DEC2 regulate the paclitaxel-induced apoptotic pathway of MCF-7 human breast cancer cells Int. J. Mol. Med. 27 2011 491 495
10. D. Pineiro, V.M. Gonzalez, M. Salinas, and M. Elena Martin Analysis of the protein expression changes during taxol-induced apoptosis under translation inhibition conditions Mol. Cell. Biochem. 345 2010 131 144
11. D.C. Schultz, K. Ayyanathan, D. Negorev, G.G. Maul, and F.J. Rauscher 3rd. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins Genes Dev. 16 2002 919 932
12. E. Bolderson, K.I. Savage, R. Mahen, V. Pisupati, M.E. Graham, D.J. Richard, P.J. Robinson, A.R. Venkitaraman, and K.K. Khanna Kruppel-associated box (KRAB)-associated co-repressor (KAP-1) ser-473 phosphorylation regulates heterochromatin protein 1beta (HP1-beta) mobilization and DNA repair in heterochromatin J. Biol. Chem. 287 2012 28122 28131
13. H. Hashimoto, P.M. Vertino, and X. Cheng Molecular coupling of DNA methylation and histone methylation Epigenomics 2 2010 657 669
14. S.L. Tan, M. Nishi, T. Ohtsuka, T. Matsui, K. Takemoto, A. Kamio-Miura, H. Aburatani, Y. Shinkai, and R. Kageyama Essential roles of the histone methyltransferase ESET in the epigenetic control of neural progenitor cells during development Development 139 2012 3806 3816
15. L.E. Lundberg, P. Stenberg, and J. Larsson HP1a, su(var)3-9, SETDB1 and POF stimulate or repress gene expression depending on genomic position, gene length and expression pattern in Drosophila melanogaster Nucleic Acids Res. 41 2013 4481 4494
16. J.A. Park, A.J. Kim, Y. Kang, Y.J. Jung, H.K. Kim, and K.C. Kim Deacetylation and methylation at histone H3 lysine 9 (H3K9) coordinate chromosome condensation during cell cycle progression Mol. Cells 31 2011 343 349
17. K. Tabata, H. Sakai, R. Nakajima, R. Saya-Nishimura, K. Motani, S. Okano, Y. Shibata, Y. Abiko, and T. Suzuki Acute application of cisplatin affects methylation status in neuroblastoma cells Oncol. Rep. 25 2011 1655 1660
18. J.A. Park, and K.C. Kim Expression patterns of PRDM10 during mouse embryonic development BMB Rep. 43 2010 29 33
19. J.K. Lee, and K.C. Kim DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells Biochem. Biophys. Res. Commun. 438 2013 647 652
20. Y. Shang, X. Hu, J. DiRenzo, M.A. Lazar, and M. Brown Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription Cell 103 2000 843 852
21. P. Giannakakou, R. Robey, T. Fojo, and M.V. Blagosklonny Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity Oncogene 20 2001 3806 3813
22. S. Rea, F. Eisenhaber, D. O'Carroll, B.D. Strahl, Z.W. Sun, M. Schmid, S. Opravil, K. Mechtler, C.P. Ponting, C.D. Allis, and T. Jenuwein Regulation of chromatin structure by site-specific histone H3 methyltransferases Nature 406 2000 593 599
23. N. Bansal, R. Kadamb, S. Mittal, L. Vig, R. Sharma, B.S. Dwarakanath, and D. Saluja Tumor suppressor protein p53 recruits human Sin3B/HDAC1 complex for down-regulation of its target promoters in response to genotoxic stress PLoS One 6 2011 e26156
24. T. Miyashita, and J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
25. Y. Yu, J. Wang, W. Khaled, S. Burke, P. Li, X. Chen, W. Yang, N.A. Jenkins, N.G. Copeland, S. Zhang, and P. Liu Bcl11a is essential for lymphoid development and negatively regulates p53 J. Exp. Med. 209 2012 2467 2483
26. A. Mirza, Q. Wu, L. Wang, T. McClanahan, W.R. Bishop, F. Gheyas, W. Ding, B. Hutchins, T. Hockenberry, P. Kirschmeier, J.R. Greene, and S. Liu Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression Oncogene 22 2003 3645 3654
27. M. Rodriguez-Paredes, A. Martinez de Paz, L. Simo-Riudalbas, S. Sayols, C. Moutinho, S. Moran, A. Villanueva, M. Vazquez-Cedeira, P.A. Lazo, F. Carneiro, C.S. Moura, J. Vieira, M.R. Teixeira, and M. Esteller Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis Oncogene 2013 1 7
28. H. Watanabe, K. Soejima, H. Yasuda, I. Kawada, I. Nakachi, S. Yoda, K. Naoki, and A. Ishizaka Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells Cancer Cell Int. 8 2008 1 12
29. J. Zhou, C. Bi, L.L. Cheong, S. Mahara, S.C. Liu, K.G. Tay, T.L. Koh, Q. Yu, and W.J. Chng The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML Blood 118 2011 2830 2839
30. S.K. Mungamuri, E.K. Benson, S. Wang, W. Gu, S.W. Lee, and S.A. Aaronson P53-mediated heterochromatin reorganization regulates its cell fate decisions Nat. Struct. Mol. Biol. 19 2012 478 484 (S1)